Massimo Loda – Candidate for the AACR Nominating Committee

The voting for the 2025 AACR Annual Election is now open, where members will vote for the next President-Elect, Treasurer, five Board Members, and four members of the Nominating Committee. This year, Massimo Loda, MD is a candidate for the AACR Nominating Committee.

About the role

• Dr. Massimo Loda is an endowed tenured professor and chair of the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine, where he also serves as pathologist-in-chief at New York Presbyterian/Weill Cornell Medical Center.
• He holds multiple academic appointments, including visiting professor roles at Università Vita-Salute in Milan, Italy, the University of Rome, and Nuffield Surgical Sciences at Oxford University, UK.
• Dr. Loda is also professor emeritus of pathology at Harvard Medical School.
• Previously, Dr. Loda was the Newtown Abraham Professor at Oxford University, faculty at the Weill Cornell Graduate School, and interim director of the Meyer Cancer Center.
• He has held leadership roles at Dana-Farber Cancer Institute, including chair of the Department of Oncologic Pathology and director of the Molecular in Situ Hybridization and Prostate Human Pathology Cores.
• His career also includes faculty positions at Brigham and Women’s Hospital, Harvard Medical School, and the Broad Institute.

Responsibilities

• Dr. Loda’s expertise spans molecular and translational oncology, with significant contributions to the field of oncologic pathology.
• His research focuses on the role of pathology and post-translational mechanisms in cancer, with a particular emphasis on prostate cancer.
• Through these investigations, Dr. Loda aims to uncover novel therapeutic targets and biomarkers for prostate cancer.

Qualifications

• Dr. Loda’s ongoing involvement with the AACR reflects his dedication to advancing cancer research through collaborative efforts and scientific leadership.
• He has made significant contributions to the American Association for Cancer Research (AACR) in various leadership and service roles.
• Currently, he serves as the chair of the Pathology in Cancer Research Working Group and is a member of the AACR Precision Combination Therapy Task Force.
• He has held key positions such as chair of the James S. Ewing-Thelma B. Dunn Award Committee and editor-in-chief of Molecular Cancer Research.

Awards and Honors

• Chair, Scientific Advisory Board, American-Italian Cancer Foundation (2022)
• Recipient, Special Challenge Award, Prostate Cancer Foundation (2021, 2022)
• Member, External Advisory Board, University of Wisconsin Prostate SPORE (2020-present)
• Recipient, Meritorious Award, Society for Basic Urologic Research (2020)
• Recipient, William O. Russell Award, MD Anderson Cancer Research Center (2020)
• Recipient, A. David Mazzone Mentoring Career Development Award, Dana-Farber Cancer Institute (2018-2019)
• Member, Editorial Board, American Journal of Pathology (2012-2014)